Clinical Trial Update: Effectiveness and Safety of a Heterologous, Two-dose Ebola Vaccine in the DRC [Phase 3]

View source ↗

Summary

A Phase 3 trial update evaluating the effectiveness and safety of a heterologous two-dose Ebola vaccine in the Democratic Republic of the Congo.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ebola Virus Disease

Snippet

Sponsor: London School of Hygiene and Tropical Medicine | Conditions: Ebola Virus Disease | Phase 3 | Status: UNKNOWN